Response to Office Action

GENCARE GENERIC HEALTHCARE

Pioneer Life Sciences LLC

Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/30/2020)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88838968
LAW OFFICE ASSIGNED LAW OFFICE 115
MARK SECTION
MARK FILE NAME http://uspto.report/TM/88838968/mark.png
LITERAL ELEMENT GENCARE GENERIC HEALTHCARE
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
COLOR(S) CLAIMED
(If applicable)
Color is not claimed as a feature of the mark.
DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word "GenCare" above the words "generic healthcare", all to the right of a heart shape including an American flag design.
EVIDENCE SECTION
        EVIDENCE FILE NAME(S)
       ORIGINAL PDF FILE evi_962346328-20201111211 208494028_._16992.003_OA_ Response.pdf
       CONVERTED PDF FILE(S)
       (5 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0002.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0006.JPG
DESCRIPTION OF EVIDENCE FILE Arguments presented as PDF attachment.
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements
FILING BASIS Section 1(a)
        FIRST USE ANYWHERE DATE At least as early as 11/00/2018
        FIRST USE IN COMMERCE DATE At least as early as 11/00/2018
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
DESCRIPTION
Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements
FILING BASIS Section 1(a)
       FIRST USE ANYWHERE DATE At least as early as 11/00/2018
       FIRST USE IN COMMERCE DATE At least as early as 11/00/2018
       STATEMENT TYPE "The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce at least as early as the filing date of the application"[for an application based on Section 1(a), Use in Commerce] OR "The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce prior either to the filing of the Amendment to Allege Use or expiration of the filing deadline for filing a Statement of Use" [for an application based on Section 1(b) Intent-to-Use]. OR "The attached specimen is a true copy of the specimen that was originally submitted with the application, amendment to allege use, or statement of use" [for an illegible specimen].
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPU0-962346328-2020111121 1208494028_._Specimen_2_- _GGH.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\888\389\88838968\xml5\ ROA0007.JPG
       SPECIMEN DESCRIPTION Electronic display
ADDITIONAL STATEMENTS SECTION
DISCLAIMER No claim is made to the exclusive right to use GENERIC HEALTHCARE apart from the mark as shown.
DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The mark consists of the word "GenCare" above the words "generic healthcare", all to the right of a heart shape that contains a stylized representation of a partial American flag design.
CORRESPONDENCE INFORMATION (current)
NAME DANIELLE COHEN, ESQ.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademark@egsllp.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) dcohen@egsllp.com
DOCKET/REFERENCE NUMBER 16992.003
CORRESPONDENCE INFORMATION (proposed)
NAME Danielle Cohen, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademark@egsllp.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) dcohen@egsllp.com
DOCKET/REFERENCE NUMBER 16992.003
SIGNATURE SECTION
DECLARATION SIGNATURE /honeah sohail mangione/
SIGNATORY'S NAME Honeah Sohail Mangione
SIGNATORY'S POSITION Attorney of Record, NJ Bar Member
DATE SIGNED 11/11/2020
RESPONSE SIGNATURE /honeah sohail mangione/
SIGNATORY'S NAME Honeah Sohail Mangione
SIGNATORY'S POSITION Attorney of Record, New Jersey Bar Member
DATE SIGNED 11/11/2020
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Wed Nov 11 21:24:13 ET 2020
TEAS STAMP USPTO/ROA-XX.XXX.XX.XX-20
201111212413666092-888389
68-750818cf46a354ff5fbf43
964a82ca27f042244ae34cf75
83e8ea9702ef4ec98f2-N/A-N
/A-20201111211208494028



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/30/2020)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 88838968 GENCARE GENERIC HEALTHCARE (Stylized and/or with Design, see http://tmng-al.uspto.gov /resting2/api/img/8883896 8/large) has been amended as follows:

EVIDENCE
Evidence has been attached: Arguments presented as PDF attachment.
Original PDF file:
evi_962346328-20201111211 208494028_._16992.003_OA_ Response.pdf
Converted PDF file(s) ( 5 pages) Evidence-1Evidence-2Evidence-3Evidence-4Evidence-5

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 005 for Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 11/00/2018 and first used in commerce at least as early as 11/00/2018 , and is now in use in such commerce.


Proposed:
Class 005 for Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 11/00/2018 and first used in commerce at least as early as 11/00/2018 , and is now in use in such commerce.
Applicant hereby submits one(or more) specimen(s) for Class 005. The specimen(s) submitted consists of Electronic display.
"The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce at least as early as the filing date of the application"[for an application based on Section 1(a), Use in Commerce] OR "The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce prior either to the filing of the Amendment to Allege Use or expiration of the filing deadline for filing a Statement of Use" [for an application based on Section 1(b) Intent-to-Use]. OR "The attached specimen is a true copy of the specimen that was originally submitted with the application, amendment to allege use, or statement of use" [for an illegible specimen].
Original PDF file:
SPU0-962346328-2020111121 1208494028_._Specimen_2_- _GGH.pdf
Converted PDF file(s) ( 1 page) Specimen File1

ADDITIONAL STATEMENTS
Disclaimer
No claim is made to the exclusive right to use GENERIC HEALTHCARE apart from the mark as shown.


Description of mark
The mark consists of The mark consists of the word "GenCare" above the words "generic healthcare", all to the right of a heart shape that contains a stylized representation of a partial American flag design.
Correspondence Information (current):
      DANIELLE COHEN, ESQ.
      PRIMARY EMAIL FOR CORRESPONDENCE: trademark@egsllp.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): dcohen@egsllp.com

The docket/reference number is 16992.003.
Correspondence Information (proposed):
      Danielle Cohen, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: trademark@egsllp.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): dcohen@egsllp.com

The docket/reference number is 16992.003.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Declaration Signature

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that, if the applicant submitted the application or allegation of use (AOU) unsigned, all statements in the application or AOU and this submission based on the signatory's own knowledge are true, and all statements in the application or AOU and this submission made on information and belief are believed to be true.

STATEMENTS FOR UNSIGNED SECTION 1(a) APPLICATION/AOU: If the applicant filed an unsigned application under 15 U.S.C. §1051(a) or AOU under 15 U.S.C. §1051(c), the signatory additionally believes that: the applicant is the owner of the mark sought to be registered; the mark is in use in commerce and was in use in commerce as of the filing date of the application or AOU on or in connection with the goods/services/collective membership organization in the application or AOU; the original specimen(s), if applicable, shows the mark in use in commerce as of the filing date of the application or AOU on or in connection with the goods/services/collective membership organization in the application or AOU; for a collective trademark, collective service mark, collective membership mark application, or certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce and was exercising legitimate control over the use of the mark in commerce as of the filing date of the application or AOU; for a certification mark application, the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant. To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

STATEMENTS FOR UNSIGNED SECTION 1(b)/SECTION 44 APPLICATION AND FOR SECTION 66(a) COLLECTIVE/CERTIFICATION MARK APPLICATION: If the applicant filed an unsigned application under 15 U.S.C. §§ 1051(b), 1126(d), and/or 1126(e), or filed a collective/certification mark application under 15 U.S.C. §1141f(a), the signatory additionally believes that: for a trademark or service mark application, the applicant is entitled to use the mark in commerce on or in connection with the goods/services specified in the application; the applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date; for a collective trademark, collective service mark, collective membership mark, or certification mark application, the applicant has a bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce and had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce as of the application filing date; the signatory is properly authorized to execute the declaration on behalf of the applicant; for a certification mark application, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant. To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.



Signature: /honeah sohail mangione/      Date: 11/11/2020
Signatory's Name: Honeah Sohail Mangione
Signatory's Position: Attorney of Record, NJ Bar Member

Response Signature
Signature: /honeah sohail mangione/     Date: 11/11/2020
Signatory's Name: Honeah Sohail Mangione
Signatory's Position: Attorney of Record, New Jersey Bar Member

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    DANIELLE COHEN, ESQ.
   ELLENOFF GROSSMAN & SCHOLE LLP
   FLOOR 15
   1345 AVE OF THE AMERICAS
   NEW YORK, New York 10105
Mailing Address:    Danielle Cohen, Esq.
   ELLENOFF GROSSMAN & SCHOLE LLP
   FLOOR 15
   1345 AVE OF THE AMERICAS
   NEW YORK, New York 10105
        
Serial Number: 88838968
Internet Transmission Date: Wed Nov 11 21:24:13 ET 2020
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XX-20201111212413666
092-88838968-750818cf46a354ff5fbf43964a8
2ca27f042244ae34cf7583e8ea9702ef4ec98f2-
N/A-N/A-20201111211208494028


Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed